Clinical Trial Update: Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 genotype-directed dose-escalation study of irinotecan in patients with advanced solid tumors, conducted by the University of Chicago. The trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: University of Chicago | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED